{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T22:26:35Z","timestamp":1759616795674},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1097\/fpc.0000000000000088","type":"journal-article","created":{"date-parts":[[2014,8,29]],"date-time":"2014-08-29T11:26:50Z","timestamp":1409311610000},"page":"556-563","source":"Crossref","is-referenced-by-count":7,"title":["Pharmacogenetic effects of \u2018candidate gene complexes\u2019 on stroke in the GenHAT study"],"prefix":"10.1097","volume":"24","author":[{"given":"Izel F.","family":"S\u00f8rensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana I.","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marguerite R.","family":"Irvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry R.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles E.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Boerwinkle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Eckfeldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna K.","family":"Arnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-4-20210213","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1001\/jama.289.18.2363","article-title":". Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States.","volume":"289","author":"Wolf-Maier","year":"2003","journal-title":"JAMA"},{"key":"R4-4-20210213","doi-asserted-by":"crossref","first-page":"e003423","DOI":"10.1136\/bmjopen-2013-003423","article-title":". Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study.","volume":"3","author":"Joffres","year":"2013","journal-title":"BMJ Open"},{"key":"R5-4-20210213","first-page":"e28","article-title":"American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2014 update: a report from the American Heart Association.","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"R7-4-20210213","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0140-6736(00)03307-9","article-title":"Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials.","volume":"356","author":"Neal","year":"2000","journal-title":"Lancet"},{"key":"R8-4-20210213","first-page":"933","article-title":"Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, CDC. Vital Signs: Prevalence, Treatment, and Control of Hypertension - United States, 1999-2002 and 2005-2008.","volume":"123","author":"Gillespie","year":"2011","journal-title":"Circulation"},{"key":"R9-4-20210213","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1161\/HYPERTENSIONAHA.107.107086","article-title":"Screening, treatment, and control of hypertension in US private physician offices, 2003-2004.","volume":"51","author":"Ma","year":"2008","journal-title":"Hypertension"},{"key":"R10-4-20210213","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1291\/hypres.29.143","article-title":"Current status of antihypertensive prescription and associated blood pressure control in Japan.","volume":"29","author":"Mori","year":"2006","journal-title":"Hypertens Res"},{"key":"R11-4-20210213","first-page":"753","article-title":"Working group of arterial hypertension of the Spanish Society of Primary Care physicians (Group HTASEMERGEN); PRESCAP 2006 investigators. Blood pressure control and physicians therapeutic behavior in a very elderly Spanish hypertensive population.","volume":"32","author":"Rodriguez-Roca","year":"2009","journal-title":"Hypertens Res"},{"key":"R12-4-20210213","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/jhh.2009.76","article-title":"Antihypertensive drug therapy and blood pressure control in men and women: an international perspective.","volume":"24","author":"Thoenes","year":"2010","journal-title":"J Hum Hypertens"},{"key":"R13-4-20210213","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1023\/A:1007860115489","article-title":"Genetic mapping and tailored antihypertensive therapy.","volume":"14","author":"Ferrari","year":"2000","journal-title":"Cardiovasc Drugs Ther"},{"key":"R15-4-20210213","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/ndt\/gfq091","article-title":"Dissecting the genetics of complex traits: lessons from hypertension.","volume":"25","author":"Navis","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R16-4-20210213","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1375\/twin.9.2.205","article-title":"Heritability and stability of resting blood pressure in Australian twins.","volume":"9","author":"Hottenga","year":"2006","journal-title":"Twin Res Hum Genet"},{"key":"R17-4-20210213","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/ng.361","article-title":"Wellcome Trust Case Control Consortium. Genome-wide association study identifies eight loci associated with blood pressure.","volume":"41","author":"Newton-Cheh","year":"2009","journal-title":"Nat Genet"},{"key":"R18-4-20210213","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/nature09410","article-title":". Hundreds of variants clustered in genomic loci and biological pathways affect human height.","volume":"467","author":"Lango Allen","year":"2010","journal-title":"Nature"},{"key":"R19-4-20210213","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1126\/science.1222794","article-title":". Systematic localization of common disease-associated variation in regulatory DNA.","volume":"337","author":"Maurano","year":"2012","journal-title":"Science"},{"key":"R20-4-20210213","doi-asserted-by":"crossref","first-page":"14035","DOI":"10.1073\/pnas.1210730109","article-title":". Genetic and environmental risk factors in congenital heart disease functionally converge in protein networks driving heart development.","volume":"109","author":"Lage","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R21-4-20210213","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nature10989","article-title":". Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations.","volume":"485","author":"ORoak","year":"2012","journal-title":"Nature"},{"key":"R22-4-20210213","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/sj.tpj.6500113","article-title":"Pharmacogenetic approaches to hypertension therapy: design and rationale for the Genetics of Hypertension Associated Treatment (GenHAT) study.","volume":"2","author":"Arnett","year":"2002","journal-title":"Pharmacogenomics J"},{"key":"R23-4-20210213","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0895-7061(96)00037-4","article-title":". Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group.","volume":"9","author":"Davis","year":"1996","journal-title":"Am J Hypertens"},{"key":"R24-4-20210213","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1001\/jama.283.15.1967","article-title":"The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).","volume":"283","year":"2000","journal-title":"JAMA"},{"key":"R26-4-20210213","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/tpj.2012.22","article-title":". RYR3 gene polymorphisms and cardiovascular disease outcomes in the context of antihypertensive treatment.","volume":"13","author":"Lynch","year":"2013","journal-title":"Pharmacogenomics J"},{"key":"R27-4-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00129785-200505010-00001","article-title":"The epidemiologic approach to pharmacogenomics.","volume":"5","author":"Little","year":"2005","journal-title":"Am J Pharmacogenomics"},{"key":"R28-4-20210213","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing.","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B"},{"key":"R29-4-20210213","doi-asserted-by":"crossref","first-page":"D808","DOI":"10.1093\/nar\/gks1094","article-title":". STRING v9.1: protein-protein interaction networks, with increased coverage and integration.","volume":"41","author":"Franceschini","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"R30-4-20210213","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/hmg\/ddn341","article-title":". Identification of a common variant at the NOS1AP locus strongly associated to QT-interval duration.","volume":"18","author":"Eijgelsheim","year":"2009","journal-title":"Hum Mol Genet"},{"key":"R31-4-20210213","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.jacc.2012.01.025","article-title":". Prolongation of QTc and risk of stroke: The REGARDS (REasons for Geographic and Racial Differences in Stroke) study.","volume":"59","author":"Soliman","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R32-4-20210213","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCULATIONAHA.106.676783","article-title":". Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study.","volume":"116","author":"Aarnoudse","year":"2007","journal-title":"Circulation"},{"key":"R33-4-20210213","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000103630","article-title":". Associations between genetic variants in the NOS1AP (CAPON) gene and cardiac repolarization in the old order Amish.","volume":"64","author":"Post","year":"2007","journal-title":"Hum Hered"},{"key":"R34-4-20210213","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/CIRCULATIONAHA.108.791723","article-title":". Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations.","volume":"119","author":"Kao","year":"2009","journal-title":"Circulation"},{"key":"R35-4-20210213","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2337\/db07-1365","article-title":". Association of NOS1AP genetic variants with QT interval duration in families from the Diabetes Heart Study.","volume":"57","author":"Lehtinen","year":"2008","journal-title":"Diabetes"},{"key":"R36-4-20210213","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/07853890802392529","article-title":"Common variation in NOS1AP and KCNH2 genes and QT interval duration in young adults. The Cardiovascular Risk in Young Finns Study.","volume":"41","author":"Raitakari","year":"2009","journal-title":"Ann Med"},{"key":"R37-4-20210213","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ng1790","article-title":". A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization.","volume":"38","author":"Arking","year":"2006","journal-title":"Nat Genet"},{"key":"R38-4-20210213","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa0900094","article-title":". Genomewide association studies of stroke.","volume":"360","author":"Ikram","year":"2009","journal-title":"N Engl J Med"},{"key":"R39-4-20210213","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1523\/JNEUROSCI.20-01-00187.2000","article-title":"Ninjurin2, a novel homophilic adhesion molecule, is expressed in mature sensory and enteric neurons and promotes neurite outgrowth.","volume":"20","author":"Araki","year":"2000","journal-title":"J Neurosci"},{"key":"R40-4-20210213","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/CIRCGENETICS.109.895763","article-title":". Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium.","volume":"3","author":"Smith","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"R41-4-20210213","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nrg2042","article-title":"FrizzledPCP signalling: a conserved mechanism regulating cell polarity and directed motility.","volume":"8","author":"Seifert","year":"2007","journal-title":"Nat Rev Genet"},{"key":"R42-4-20210213","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ajhg.2008.10.003","article-title":". A homozygous mutation in human PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome.","volume":"83","author":"Bassuk","year":"2008","journal-title":"Am J Hum Genet"},{"key":"R43-4-20210213","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ajhg.2010.12.012","article-title":". Mutations in prickle orthologs cause seizures in flies, mice, and humans.","volume":"88","author":"Tao","year":"2011","journal-title":"Am J Hum Genet"},{"key":"R44-4-20210213","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neulet.2009.09.050","article-title":"Prickle promotes neurite outgrowth via the Dishevelled dependent pathway in C1300 cells.","volume":"467","author":"Fujimura","year":"2009","journal-title":"Neurosci Lett"},{"key":"R45-4-20210213","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/01.STR.0000126208.14181.DD","article-title":"Blood pressure and stroke: an overview of published reviews.","volume":"35","author":"Lawes","year":"2004","journal-title":"Stroke"},{"key":"R46-4-20210213","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11906-013-0372-1","article-title":"Chlorthalidone: mechanisms of action and effect on cardiovascular events.","volume":"15","author":"Roush","year":"2013","journal-title":"Curr Hypertens Rep"},{"key":"R47-4-20210213","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/oxfordjournals.aje.a008915","article-title":"Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls!","volume":"144","author":"Khoury","year":"1996","journal-title":"Am J Epidemiol"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FPC.0000000000000088","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T02:13:10Z","timestamp":1717294390000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-201411000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0000000000000088","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}